| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
Published online before print July 22, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
Department of Biomedical Sciences and Technology, University of Udine, I-33100 Udine, and National Laboratory CIB, AREA Science Park, Padriciano 99, I-34012 Trieste
@ To whom correspondence should be addressed. E-mail: zanetti{at}icgeb.trieste.it.
 |
Abstract |
|---|
Cathelicidins comprise a family of mammalian proteins containing a C-terminal cationic antimicrobial domain that becomes active after being freed from the N-terminal cathelin portion of the holoprotein. Many other members of this family have been identified since the first cathelicidin sequences were reported 10 years ago. The mature peptides generally show a wide spectrum of antimicrobial activity and, more recently, some of them have also been found to exert other biological activities. The human cathelicidin peptide LL-37 is chemotactic for neutrophils, monocytes, mast cells, and T cells; induces degranulation of mast cells; alters transcriptional responses in macrophages; and stimulates wound vascularization and re-epithelialization of healing skin. The porcine PR-39 has also been involved in a variety of processes, including promotion of wound repair, induction of angiogenesis, neutrophils, chemotaxis, and inhibition of the phagocyte NADPH oxidase activity, whereas the bovine BMAP-28 induces apoptosis in transformed cell lines and activated lymphocytes and may thus help with clearance of unwanted cells at inflammation sites. These multiple actions provide evidence for active participation of cathelicidin peptides in the regulation of the antimicrobial host defenses.
Key Words: cathelin • antimicrobial peptide • innate immunity • infection
This article has been cited by other articles:
|
|
 |
|
  A. E. Garcia, G. Osapay, P. A. Tran, J. Yuan, and M. E. Selsted Isolation, Synthesis, and Antimicrobial Activities of Naturally Occurring {theta}-Defensin Isoforms from Baboon Leukocytes Infect. Immun., December 1, 2008; 76(12): 5883 - 5891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Tomasinsig, C. Pizzirani, B. Skerlavaj, P. Pellegatti, S. Gulinelli, A. Tossi, F. D. Virgilio, and M. Zanetti The Human Cathelicidin LL-37 Modulates the Activities of the P2X7 Receptor in a Structure-dependent Manner J. Biol. Chem., November 7, 2008; 283(45): 30471 - 30481. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Boehmer, D. D. Bannerman, K. Shefcheck, and J. L. Ward Proteomic Analysis of Differentially Expressed Proteins in Bovine Milk During Experimentally Induced Escherichia coli Mastitis J Dairy Sci, November 1, 2008; 91(11): 4206 - 4218. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Diamond, N. Beckloff, and L.K. Ryan Host Defense Peptides in the Oral Cavity and the Lung: Similarities and Differences J. Dent. Res., October 1, 2008; 87(10): 915 - 927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. White Vitamin D Signaling, Infectious Diseases, and Regulation of Innate Immunity Infect. Immun., September 1, 2008; 76(9): 3837 - 3843. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Wang, K. M. Watson, and R. W. Buckheit Jr. Anti-Human Immunodeficiency Virus Type 1 Activities of Antimicrobial Peptides Derived from Human and Bovine Cathelicidins Antimicrob. Agents Chemother., September 1, 2008; 52(9): 3438 - 3440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xu, C. B. Holzman, C. G. Arvidson, H. Chung, and A. R. Goepfert Midpregnancy Vaginal Fluid Defensins, Bacterial Vaginosis, and Risk of Preterm Delivery Obstet. Gynecol., September 1, 2008; 112(3): 524 - 531. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Mendez-Samperio, E. Miranda, and A. Trejo Expression and Secretion of Cathelicidin LL-37 in Human Epithelial Cells after Infection by Mycobacterium bovis Bacillus Calmette-Guerin Clin. Vaccine Immunol., September 1, 2008; 15(9): 1450 - 1455. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kobayashi, T. Yoshida, D. Takeuchi, V. C. Jones, K. Shigematsu, D. N. Herndon, and F. Suzuki Gr-1+CD11b+ cells as an accelerator of sepsis stemming from Pseudomonas aeruginosa wound infection in thermally injured mice J. Leukoc. Biol., June 1, 2008; 83(6): 1354 - 1362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Di Nardo, K. Yamasaki, R. A. Dorschner, Y. Lai, and R. L. Gallo Mast Cell Cathelicidin Antimicrobial Peptide Prevents Invasive Group A Streptococcus Infection of the Skin J. Immunol., June 1, 2008; 180(11): 7565 - 7573. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harder, R. Glaser, and J.-M. Schroder Review: Human antimicrobial proteins effectors of innate immunity Innate Immunity, December 1, 2007; 13(6): 317 - 338. [Abstract] [PDF]
|
|
|
|
 |
|
 M. Zasloff Antimicrobial Peptides, Innate Immunity, and the Normally Sterile Urinary Tract J. Am. Soc. Nephrol., November 1, 2007; 18(11): 2810 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-F. Bu, X. Wang, Y.-Q. Zhu, R. Y. Williams, W. Hsueh, X. Zheng, R. A. Rozenfeld, X.-L. Zuo, and X.-D. Tan Lysozyme-Modified Probiotic Components Protect Rats against Polymicrobial Sepsis: Role of Macrophages and Cathelicidin-Related Innate Immunity J. Immunol., December 15, 2006; 177(12): 8767 - 8776. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bergman, L. Johansson, H. Wan, A. Jones, R. L. Gallo, G. H. Gudmundsson, T. Hokfelt, A.-B. Jonsson, and B. Agerberth Induction of the Antimicrobial Peptide CRAMP in the Blood-Brain Barrier and Meninges after Meningococcal Infection Infect. Immun., December 1, 2006; 74(12): 6982 - 6991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mookherjee, H. L. Wilson, S. Doria, Y. Popowych, R. Falsafi, J. Yu, Y. Li, S. Veatch, F. M. Roche, K. L. Brown, et al. Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide J. Leukoc. Biol., December 1, 2006; 80(6): 1563 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Benincasa, M. Scocchi, S. Pacor, A. Tossi, D. Nobili, G. Basaglia, M. Busetti, and R. Gennaro Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts J. Antimicrob. Chemother., November 1, 2006; 58(5): 950 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Cirioni, A. Giacometti, C. Silvestri, A. Della Vittoria, A. Licci, A. Riva, and G. Scalise In Vitro Activities of Tritrpticin Alone and in Combination with Other Antimicrobial Agents against Pseudomonas aeruginosa Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3923 - 3925. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yamasaki, J. Schauber, A. Coda, H. Lin, R. A. Dorschner, N. M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R. L. Gallo Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J, October 1, 2006; 20(12): 2068 - 2080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Grubor, D. K. Meyerholz, and M. R. Ackermann Collectins and cationic antimicrobial peptides of the respiratory epithelia. Vet. Pathol., September 1, 2006; 43(5): 595 - 612. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. G. Barlow, Y. Li, T. S. Wilkinson, D. M. E. Bowdish, Y. E. Lau, C. Cosseau, C. Haslett, A. J. Simpson, R. E. W. Hancock, and D. J. Davidson The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system J. Leukoc. Biol., September 1, 2006; 80(3): 509 - 520. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Zelezetsky, A. Pontillo, L. Puzzi, N. Antcheva, L. Segat, S. Pacor, S. Crovella, and A. Tossi Evolution of the Primate Cathelicidin: CORRELATION BETWEEN STRUCTURAL VARIATIONS AND ANTIMICROBIAL ACTIVITY J. Biol. Chem., July 21, 2006; 281(29): 19861 - 19871. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Jenssen, P. Hamill, and R. E. W. Hancock Peptide Antimicrobial Agents Clin. Microbiol. Rev., July 1, 2006; 19(3): 491 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Raqib, P. Sarker, P. Bergman, G. Ara, M. Lindh, D. A. Sack, K. M. Nasirul Islam, G. H. Gudmundsson, J. Andersson, and B. Agerberth From the Cover: Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic PNAS, June 13, 2006; 103(24): 9178 - 9183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Zasloff Inducing endogenous antimicrobial peptides to battle infections PNAS, June 13, 2006; 103(24): 8913 - 8914. [Full Text] [PDF]
|
|
|
|
|
|
O. Cirioni, A. Giacometti, R. Ghiselli, C. Bergnach, F. Orlando, C. Silvestri, F. Mocchegiani, A. Licci, B. Skerlavaj, M. Rocchi, et al. LL-37 Protects Rats against Lethal Sepsis Caused by Gram-Negative Bacteria. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1672 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Lievin-Le Moal and A. L. Servin The Front Line of Enteric Host Defense against Unwelcome Intrusion of Harmful Microorganisms: Mucins, Antimicrobial Peptides, and Microbiota Clin. Microbiol. Rev., April 1, 2006; 19(2): 315 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Elahi, R. M. Buchanan, S. Attah-Poku, H. G. G. Townsend, L. A. Babiuk, and V. Gerdts The Host Defense Peptide Beta-Defensin 1 Confers Protection against Bordetella pertussis in Newborn Piglets Infect. Immun., April 1, 2006; 74(4): 2338 - 2352. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Mookherjee, K. L. Brown, D. M. E. Bowdish, S. Doria, R. Falsafi, K. Hokamp, F. M. Roche, R. Mu, G. H. Doho, J. Pistolic, et al. Modulation of the TLR-Mediated Inflammatory Response by the Endogenous Human Host Defense Peptide LL-37 J. Immunol., February 15, 2006; 176(4): 2455 - 2464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Xiao, Y. Cai, Y. R. Bommineni, S. C. Fernando, O. Prakash, S. E. Gilliland, and G. Zhang Identification and Functional Characterization of Three Chicken Cathelicidins with Potent Antimicrobial Activity J. Biol. Chem., February 3, 2006; 281(5): 2858 - 2867. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Baranska-Rybak, A. Sonesson, R. Nowicki, and A. Schmidtchen Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids J. Antimicrob. Chemother., February 1, 2006; 57(2): 260 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tomasinsig, B. Skerlavaj, N. Papo, B. Giabbai, Y. Shai, and M. Zanetti Mechanistic and Functional Studies of the Interaction of a Proline-rich Antimicrobial Peptide with Mammalian Cells J. Biol. Chem., January 6, 2006; 281(1): 383 - 391. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Nordahl, V. Rydengard, M. Morgelin, and A. Schmidtchen Domain 5 of High Molecular Weight Kininogen Is Antibacterial J. Biol. Chem., October 14, 2005; 280(41): 34832 - 34839. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Braff, M. Zaiou, J. Fierer, V. Nizet, and R. L. Gallo Keratinocyte Production of Cathelicidin Provides Direct Activity against Bacterial Skin Pathogens Infect. Immun., October 1, 2005; 73(10): 6771 - 6781. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Patil, Y. Cai, Y. Sang, F. Blecha, and G. Zhang Cross-species analysis of the mammalian {beta}-defensin gene family: presence of syntenic gene clusters and preferential expression in the male reproductive tract Physiol Genomics, September 21, 2005; 23(1): 5 - 17. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M.E. Bowdish and R. E.W. Hancock Anti-endotoxin properties of cationic host defence peptides and proteins Innate Immunity, August 1, 2005; 11(4): 230 - 236. [Abstract] [PDF]
|
|
|
|
|
|
D. M. E. Bowdish, D. J. Davidson, M. G. Scott, and R. E. W. Hancock Immunomodulatory Activities of Small Host Defense Peptides Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1727 - 1732. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Deng, S. Chen, Q. Li, S.-c. Lyu, C. Clayberger, and A. M. Krensky Granulysin, a Cytolytic Molecule, Is Also a Chemoattractant and Proinflammatory Activator J. Immunol., May 1, 2005; 174(9): 5243 - 5248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Iimura, R. L. Gallo, K. Hase, Y. Miyamoto, L. Eckmann, and M. F. Kagnoff Cathelicidin Mediates Innate Intestinal Defense against Colonization with Epithelial Adherent Bacterial Pathogens J. Immunol., April 15, 2005; 174(8): 4901 - 4907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Borregaard, K. Theilgaard-Monch, J. B. Cowland, M. Stahle, and O. E. Sorensen Neutrophils and keratinocytes in innate immunity--cooperative actions to provide antimicrobial defense at the right time and place J. Leukoc. Biol., April 1, 2005; 77(4): 439 - 443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. van Wetering, G. S. Tjabringa, and P. S. Hiemstra Interactions between neutrophil-derived antimicrobial peptides and airway epithelial cells J. Leukoc. Biol., April 1, 2005; 77(4): 444 - 450. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Harder and J.-M. Schroder Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins J. Leukoc. Biol., April 1, 2005; 77(4): 476 - 486. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Braff, M. A. Hawkins, A. D. Nardo, B. Lopez-Garcia, M. D. Howell, C. Wong, K. Lin, J. E. Streib, R. Dorschner, D. Y. M. Leung, et al. Structure-Function Relationships among Human Cathelicidin Peptides: Dissociation of Antimicrobial Properties from Host Immunostimulatory Activities J. Immunol., April 1, 2005; 174(7): 4271 - 4278. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nyberg, M. Rasmussen, and L. Bjorck {alpha}2-Macroglobulin-Proteinase Complexes Protect Streptococcus pyogenes from Killing by the Antimicrobial Peptide LL-37 J. Biol. Chem., December 17, 2004; 279(51): 52820 - 52823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Levy Antimicrobial proteins and peptides: anti-infective molecules of mammalian leukocytes J. Leukoc. Biol., November 1, 2004; 76(5): 909 - 925. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schaffner, C. C. King, D. Schaer, and D. G. Guiney Induction and antimicrobial activity of platelet basic protein derivatives in human monocytes J. Leukoc. Biol., November 1, 2004; 76(5): 1010 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tomasinsig, M. Scocchi, R. Mettulio, and M. Zanetti Genome-Wide Transcriptional Profiling of the Escherichia coli Response to a Proline-Rich Antimicrobial Peptide Antimicrob. Agents Chemother., September 1, 2004; 48(9): 3260 - 3267. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
